HRES 1117 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Expressing support for the designation of March as "Multiple System Atrophy Awareness Month" to strengthen public awareness of this neurodegenerative disorder.
Expressing support for the designation of March as ``Multiple System Atrophy Awareness Month'' to strengthen public awareness of this neurodegenerative disorder.
Summary
The resolution expresses support for designating March as "Multiple System Atrophy Awareness Month" to increase public awareness of this rare neurodegenerative disorder. Multiple System Atrophy affects an estimated 25,000 to 75,000 people in the United States each year and has no known cure or treatment. The resolution notes that the disorder is often misdiagnosed as Parkinson's disease and that increased public awareness could improve diagnosis and research efforts. The resolution supports funding for research related to Multiple System Atrophy to develop treatments and therapeutics.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Rep. Mullin, Kevin [D-CA-15] (D-CA)
Money behind the sponsor
Top reported contributors to Kevin Mullin’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $27,140
- ARTICHOKE JOES $16,500
- GILEAD SCIENCES $9,500
- PETER J MANDELL MD PC $6,600
- SKYKNIGHT CAPITAL $6,600
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Kevin Mullin → · Outside spending →
Actions (2)
- Mar 16, 2026 Referred to the House Committee on Energy and Commerce. · house
- Mar 16, 2026 Submitted in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE HOUSE OF REPRESENTATIVES
March 16, 2026
Mr. Mullin submitted the following resolution; which was referred to the Committee on Energy and Commerce
RESOLUTION
Expressing support for the designation of March as “Multiple System Atrophy Awareness Month” to strengthen public awareness of this neurodegenerative disorder.
Whereas Multiple System Atrophy is a rare and often fatal neurodegenerative disorder that affects 25,000-75,000 people in the United States each year; Whereas individuals diagnosed with Multiple System Atrophy have trouble walking, eating, and speaking; Whereas Multiple System Atrophy is often fatal and causes difficulty breathing, infections, or blood clots in the lungs; Whereas the cause of Multiple System Atrophy is unknown, including the degree to which genetics or environmental factors influence the disorder; Whereas Multiple System Atrophy is often misdiagnosed as Parkinson’s disease or progressive supranuclear palsy; Whereas there is no known cure or treatment for Multiple System Atrophy; Whereas a lack of awareness of Multiple System Atrophy hinders research efforts and contributes to misdiagnoses; Whereas groundbreaking scientific research is strengthening understanding of the disease and getting closer to the development of therapeutics and treatments for Multiple System Atrophy, such as at the Multiple System Atrophy Center of Excellence at Stanford School of Medicine; and Whereas public support and greater awareness of Multiple System Atrophy, as well as investments in research, can promote a better understanding of the disease and facilitate progress towards a cure: Now, therefore, be it Resolved, That the House of Representatives supports the designation of “Multiple System Atrophy Awareness Month” to strengthen public awareness of this neurodegenerative disorder and supports funding for research related to Multiple System Atrophy in hopes of developing therapeutics and treatments. <all>
Comments